Home / Recalls / Jubilant Cadista Pharmaceuticals, Inc. / D-0752-2022

D-0752-2022 Class III Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

Recall Details

Product Type
Drugs
Report Date
April 13, 2022
Initiation Date
April 1, 2022
Termination Date
April 3, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,222 Bottles (100-count)

Product Description

Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06

Reason for Recall

Subpotent

Distribution Pattern

Nationwide in the USA and Puerto Rico

Code Information

Lot # 21 P0322, Exp. 01/2023

Other recalls by Jubilant Cadista Pharmaceuticals, Inc.

  • D-0096-2023 Class III — Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadist (December 27, 2022)
  • D-1293-2022 Class II — Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jub (July 18, 2022)
  • D-1294-2022 Class II — Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubi (July 18, 2022)
  • D-0767-2022 Class I — Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles ( (March 8, 2022)
  • D-0784-2021 Class III — Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jub (August 20, 2021)
  • D-0333-2021 Class II — Itraconazole Capsules, 100 mg, 30-count bottles, Rx only, Manufactured by: Jubil (April 1, 2021)
  • D-0298-2021 Class III — Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx on (February 19, 2021)
  • D-0104-2021 Class II — clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufa (November 6, 2020)
  • D-0066-2021 Class III — Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) bliste (October 26, 2020)
  • D-1281-2020 Class III — Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: (May 26, 2020)